Treatment Analysis in a Cancer Stem Cell Context Using a Tumor Growth Model Based on Cellular Automata

PLoS One. 2015 Jul 15;10(7):e0132306. doi: 10.1371/journal.pone.0132306. eCollection 2015.

Abstract

Cancer can be viewed as an emergent behavior in terms of complex system theory and artificial life, Cellular Automata (CA) being the tool most used for studying and characterizing the emergent behavior. Different approaches with CA models were used to model cancer growth. The use of the abstract model of acquired cancer hallmarks permits the direct modeling at cellular level, where a cellular automaton defines the mitotic and apoptotic behavior of cells, and allows for an analysis of different dynamics of the cellular system depending on the presence of the different hallmarks. A CA model based on the presence of hallmarks in the cells, which includes a simulation of the behavior of Cancer Stem Cells (CSC) and their implications for the resultant growth behavior of the multicellular system, was employed. This modeling of cancer growth, in the avascular phase, was employed to analyze the effect of cancer treatments in a cancer stem cell context. The model clearly explains why, after treatment against non-stem cancer cells, the regrowth capability of CSCs generates a faster regrowth of tumor behavior, and also shows that a continuous low-intensity treatment does not favor CSC proliferation and differentiation, thereby allowing an unproblematic control of future tumor regrowth. The analysis performed indicates that, contrary to the current attempts at CSC control, trying to make CSC proliferation more difficult is an important point to consider, especially in the immediate period after a standard treatment for controlling non-stem cancer cell proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinogenesis
  • Cell Differentiation
  • Cell Proliferation
  • Computer Simulation
  • Humans
  • Models, Biological*
  • Neoplasms / pathology
  • Neoplastic Stem Cells / cytology
  • Neoplastic Stem Cells / metabolism*

Grants and funding

This work was supported by Ministry of Economy and Competitiveness of Spain (project TIN2013-40981-R) (JS).